<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Lir Life Sciences Corp. — News on 6ix</title>
<link>https://6ix.com/company/lir-life-sciences-corp</link>
<description>Latest news and press releases for Lir Life Sciences Corp. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 29 Jan 2026 23:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/lir-life-sciences-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d6b65bbeedb30cb6ffb69d.webp</url>
<title>Lir Life Sciences Corp.</title>
<link>https://6ix.com/company/lir-life-sciences-corp</link>
</image>
<item>
<title>LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies</title>
<link>https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-reports-positive-interim-preclinical-results-from-comparative-animal-study-of-novel-cpp-enabled-transdermal-delivery-of-glpgip-based-therapies</link>
<guid isPermaLink="true">https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-reports-positive-interim-preclinical-results-from-comparative-animal-study-of-novel-cpp-enabled-transdermal-delivery-of-glpgip-based-therapies</guid>
<pubDate>Thu, 29 Jan 2026 23:00:00 GMT</pubDate>
<description>VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce positive interim results from its ongoing comparative mouse study evaluating ...</description>
</item>
<item>
<title>LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules</title>
<link>https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-completes-design-of-ex-vivo-animal-study-to-evaluate-novel-transdermal-agents-for-transport-of-larger-therapeutic-molecules</link>
<guid isPermaLink="true">https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-completes-design-of-ex-vivo-animal-study-to-evaluate-novel-transdermal-agents-for-transport-of-larger-therapeutic-molecules</guid>
<pubDate>Thu, 22 Jan 2026 23:00:00 GMT</pubDate>
<description>VANCOUVER, BC / ACCESS Newswire / January 22, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") is pleased to announce the completion of a study design for an ex vivo porcine skin investigation that is ...</description>
</item>
<item>
<title>LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies</title>
<link>https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-launches-comparative-animal-study-to-advance-transdermal-delivery-of-second-generation-glpgip-based-obesity-therapies</link>
<guid isPermaLink="true">https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-launches-comparative-animal-study-to-advance-transdermal-delivery-of-second-generation-glpgip-based-obesity-therapies</guid>
<pubDate>Thu, 15 Jan 2026 23:00:00 GMT</pubDate>
<description>VANCOUVER, BC / ACCESS Newswire / January 15, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce the launch of a controlled comparative animal study designed to evaluate ...</description>
</item>
<item>
<title>LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform</title>
<link>https://6ix.com/company/lir-life-sciences-corp/news/lir-life-engages-neuland-labs-to-advance-development-of-cell-penetrating-peptides-for-transdermal-glp-1gip-platform</link>
<guid isPermaLink="true">https://6ix.com/company/lir-life-sciences-corp/news/lir-life-engages-neuland-labs-to-advance-development-of-cell-penetrating-peptides-for-transdermal-glp-1gip-platform</guid>
<pubDate>Thu, 08 Jan 2026 23:00:00 GMT</pubDate>
<description>VANCOUVER, BC / ACCESS Newswire / January 8, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790) (WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that it has entered into a services agreement ("R&D Agreement") with ...</description>
</item>
<item>
<title>LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor</title>
<link>https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-announces-appointment-of-dr-peter-singer-as-scientific-advisor</link>
<guid isPermaLink="true">https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-announces-appointment-of-dr-peter-singer-as-scientific-advisor</guid>
<pubDate>Thu, 18 Dec 2025 23:00:00 GMT</pubDate>
<description>VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that Dr. Peter Singer, a global health expert and former Special Advisor to the Director ...</description>
</item>
<item>
<title>LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies</title>
<link>https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-files-provisional-patent-application-for-needle-free-delivery-of-glpgip-based-obesity-therapies</link>
<guid isPermaLink="true">https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-files-provisional-patent-application-for-needle-free-delivery-of-glpgip-based-obesity-therapies</guid>
<pubDate>Thu, 11 Dec 2025 23:00:00 GMT</pubDate>
<description>VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") announces that it has filed a provisional patent application intended to cover a needle-free delivery platform ...</description>
</item>
<item>
<title>Lir Life Sciences Completes Design of a Comparative Animal Study Investigating Cell-Penetrating Peptide-Mediated Delivery of GLP/GIP-Based Obesity Therapies</title>
<link>https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-completes-design-of-a-comparative-animal-study-investigating-cell-penetrating-peptide-mediated-delivery-of-glpgip-based-obesity-therapies</link>
<guid isPermaLink="true">https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-completes-design-of-a-comparative-animal-study-investigating-cell-penetrating-peptide-mediated-delivery-of-glpgip-based-obesity-therapies</guid>
<pubDate>Wed, 10 Dec 2025 23:00:00 GMT</pubDate>
<description>VANCOUVER, BC / ACCESS Newswire / December 10, 2025 / Lir Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("Lir" or the "Company") is pleased to announce the design of a new comparative cell-penetrating peptide-based uptake study (the ...</description>
</item>
<item>
<title>Lir Life Sciences Announces Engagement for IR Services</title>
<link>https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-announces-engagement-for-ir-services</link>
<guid isPermaLink="true">https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-announces-engagement-for-ir-services</guid>
<pubDate>Wed, 26 Nov 2025 22:00:00 GMT</pubDate>
<description>VANCOUVER, BC / ACCESS Newswire / November 26, 2025 / Lir Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") announces that it has engaged MCS Market Communication Service GmbH (business address: Saarlandstraße 28 ...</description>
</item>
<item>
<title>Lir Life Sciences Corp. Formerly Blackbird Critical Metals Corp. Announces Closing of Acquisition of Lir Life Sciences Inc.</title>
<link>https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-corp-formerly-blackbird-critical-metals-corp-announces-closing-of-acquisition-of-lir-life-sciences-inc</link>
<guid isPermaLink="true">https://6ix.com/company/lir-life-sciences-corp/news/lir-life-sciences-corp-formerly-blackbird-critical-metals-corp-announces-closing-of-acquisition-of-lir-life-sciences-inc</guid>
<pubDate>Mon, 10 Nov 2025 14:00:00 GMT</pubDate>
<description>VANCOUVER, BC / ACCESS Newswire / November 10, 2025 / Lir Life Sciences Corp. (CSE:SKNY) (formerly Blackbird Critical Metals Corp.) ("Lir Life Sciences" or the "Company") is pleased to announce, further to its news release dated August 14, 2025, that ...</description>
</item>
</channel>
</rss>